Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2010-09-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isoton sodium chloride
isoton sodium chloride
intravenous injection for 25 min
Prostin E2 (dinoprostone)
dinoprostone
intravenous injection 0.4 μgr/kg/min for 25 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dinoprostone
intravenous injection 0.4 μgr/kg/min for 25 min
isoton sodium chloride
intravenous injection for 25 min
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Other forms for primary headache
* Headache 24 h before the day of the investigation
* Migraine 48 h before the day of the investigation
* Hypertension
* Hypotension
* Pregnant/nursing
* Daily intake of medication (except oral contraceptives and migraine rescue medicine during migraine attack)
* Cardiovascular or central nervous system (CNS) disease
* Drug/alcohol abuse
* Psychiatric disease
* Asthma or any other lung diseases
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Troels Wienecke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Troels Wienecke
MD,PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Troels Wienecke, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Danish Headache Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Headache Center
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DHC-PGE2-2011
Identifier Type: -
Identifier Source: org_study_id